Cleared Traditional

K242129 - VitalRhythm

K242129 is an FDA 510(k) clearance for VitalRhythm, manufactured by Vitalconnect, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 269-day FDA review.

K242129 · Vitalconnect, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
269d
Days
Class 2
Risk

K242129 is an FDA 510(k) clearance for the VitalRhythm. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Vitalconnect, Inc. (San Jose, US). The FDA issued a Cleared decision on April 17, 2025 after a review of 269 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vitalconnect, Inc. devices

FDA 510(k) Submission Details - K242129

510(k) Number K242129 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 2024
Decision Date April 17, 2025
Days to Decision 269 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
144d slower than avg
Panel avg: 125d · This submission: 269d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 270
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K242129.
OptiMap™ System
K251344 · Boston Scientific Corporation · May 2025
DeepRhythmAI
K250932 · Medicalgorithmics S.A. · May 2025
Volta AF-Xplorer
K243812 · Volta Medical · May 2025
Intra-Operative Positioning System (IOPS®)
K243842 · Centerline Biomedical, Inc. · Mar 2025
CER-S
K243312 · Cardiocalm Srl · Feb 2025
Affera Integrated Mapping System
K243892 · Medtronic, Inc. · Jan 2025